FindMyKOL

Ian Cawich, MD

Basic profile

Arkansas Heart Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionLittle Rock, AR · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ian Cawich is a Cardiology physician affiliated with Arkansas Heart Hospital. OpenAlex indexes 35 publications with 902 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
35publications

Publications indexed by OpenAlex. Counts exclude supporting files.

902citations

Citations across these publications.

12h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
34companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Shockwave Medical, Inc
    Program year202547 payments
    $28,649
  • Abbott
    Program year20256 paymentsResearch
    $3,734
  • Abbott Laboratories
    Program year202517 payments
    $1,377
All 75 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    57.5%
    Beta blocker11.5%
    Metoprolol Succinate54%Metoprolol Tartrate23%Carvedilol11%Atenolol6%Sotalol4%Bisoprolol Fumarate3%
    Part D<11 patients
    Statin8.6%
    Atorvastatin Calcium53%Rosuvastatin Calcium20%Pravastatin Sodium12%Simvastatin11%Lovastatin5%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    36%
    P2Y12 inhibitor24.6%
    Clopidogrel90%Prasugrel Hcl7%Brilinta3%
    Part D<11 patients
    Factor Xa inhibitor9.6%
    Eliquis82%Xarelto18%
    Part D≥73 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    4.2%
    Potassium supplement2.3%
    Potassium Chloride100%
    Part D≥30 patients
    Proton pump inhibitor1.6%
    Omeprazole68%Pantoprazole Sodium32%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)77.5% facility · 22.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”